Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Agilon Health Q2 Sales $1.483B Miss $1.560B Estimate

Author: Benzinga Newsdesk | August 06, 2024 04:08pm
Agilon Health (NYSE:AGL) reported quarterly sales of $1.483 billion which missed the analyst consensus estimate of $1.560 billion by 4.91 percent. This is a 29.07 percent increase over sales of $1.149 billion the same period last year.

Posted In: AGL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist